首页> 外文期刊>Annals of surgical oncology >The impact of perineural invasion and/or lymphovascular invasion on the survival of early-stage oral squamous cell carcinoma patients
【24h】

The impact of perineural invasion and/or lymphovascular invasion on the survival of early-stage oral squamous cell carcinoma patients

机译:神经周浸润和/或淋巴管浸润对早期口腔鳞状细胞癌患者生存的影响

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: For early-stage oral squamous cell carcinoma (OSCC) patients, the impact of perineural invasion (PNI) and lymphovascular invasion (LVI) on disease control and survival has not been clarified. Methods: The medical records of all early-stage OSCC patients who underwent curative surgery between 2004 and 2009 were reviewed. Results: A total of 442 early stage patients were included in this study. There were 360 patients in group A (without PNI or LVI) and 82 patients in group B (with PNI and/or LVI). Between groups A and B patients, there were no significant differences in the 5-year disease-free survival (73.8 vs 68.7 %, p = 0.48) and overall survival (90.9 vs 86.1 %, p = 0.25). Between groups A and B patients without postoperative radiotherapy (PORT), there were no significant differences in the 5-year disease-free survival (73.8 vs 70.2 %, p = 0.51) and overall survival (90.9 vs 85.2 %, p = 0.18). Between group B patients with and without PORT, there was no significant difference in either the disease-free survival (61.1 vs 70.2 %, p = 0.98) and overall survival (88.9 vs 85.2 %, p = 0.64). Multivariate analyses revealed that PNI, LVI, and PORT could not provide significant effect on treatment outcome. Conclusions: PNI and LVI were not significant risk factors for the disease control and overall survival for early stage OSCC patients. Furthermore, PORT could not provide an additional benefit for the disease control and overall survival for stages I and II OSCC patients with PNI and/or LVI.
机译:背景:对于早期口腔鳞状细胞癌(OSCC)患者,神经周围浸润(PNI)和淋巴血管浸润(LVI)对疾病控制和生存的影响尚不清楚。方法:回顾了2004年至2009年间所有接受根治性手术的早期OSCC患者的病历。结果:本研究共纳入442例早期患者。 A组有360例患者(无PNI或LVI),B组有82例患者(有PNI和/或LVI)。在A组和B组患者之间,其5年无病生存期(73.8%对68.7%,p = 0.48)和总生存期(90.9对86.1%,p = 0.25)没有显着差异。在没有术后放疗(PORT)的A和B组患者之间,其5年无病生存率(73.8 vs 70.2%,p = 0.51)和总生存率(90.9 vs 85.2%,p = 0.18)没有显着差异。 。在有和没有PORT的B组患者之间,无病生存期(61.1 vs 70.2%,p = 0.98)和总生存期(88.9 vs 85.2%,p = 0.64)均无显着差异。多变量分析显示,PNI,LVI和PORT不能对治疗结果产生重大影响。结论:PNI和LVI并不是早期OSCC患者疾病控制和总体生存的重要危险因素。此外,对于I期和II期OSCC的PNI和/或LVI患者,PORT不能为疾病控制和总体生存提供额外的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号